Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor model

BACKGROUND: Glioblastoma (GBM) is the most aggressive type of brain tumor with heterogeneity and strong invasive ability. Treatment of GBM has not improved significantly despite the progress of immunotherapy and classical therapy. Epidermal growth factor receptor variant III (EGFRvIII), one of GBM-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jin Myung, Lim, Sa-Hoe, Liu, Zhi-Peng, Lee, Tae Kyu, Rhee, Joon Haeng, Yoon, Mee Sun, Min, Jung-Joon, Jung, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479269/
https://www.ncbi.nlm.nih.gov/pubmed/36109710
http://dx.doi.org/10.1186/s12885-022-10023-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479269/
https://www.ncbi.nlm.nih.gov/pubmed/36109710
http://dx.doi.org/10.1186/s12885-022-10023-6

Ejemplares similares